ZA99740B - Application of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction. - Google Patents

Application of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction.

Info

Publication number
ZA99740B
ZA99740B ZA9900740A ZA99740A ZA99740B ZA 99740 B ZA99740 B ZA 99740B ZA 9900740 A ZA9900740 A ZA 9900740A ZA 99740 A ZA99740 A ZA 99740A ZA 99740 B ZA99740 B ZA 99740B
Authority
ZA
South Africa
Prior art keywords
prevention
treatment
trifluoromethoxybenzothiazole
amino
application
Prior art date
Application number
ZA9900740A
Other languages
English (en)
Inventor
Andrees Bohme
Thierry Canton
Alain Boireau
Assunta Imperato
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA99740B publication Critical patent/ZA99740B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA9900740A 1998-02-06 1999-01-29 Application of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction. ZA99740B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9801402A FR2774592B1 (fr) 1998-02-06 1998-02-06 Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet

Publications (1)

Publication Number Publication Date
ZA99740B true ZA99740B (en) 1999-08-02

Family

ID=9522673

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9900740A ZA99740B (en) 1998-02-06 1999-01-29 Application of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction.

Country Status (18)

Country Link
US (1) US6245791B1 (xx)
EP (1) EP1052989B1 (xx)
JP (1) JP5127092B2 (xx)
KR (1) KR100574378B1 (xx)
AT (1) ATE245982T1 (xx)
AU (1) AU761978B2 (xx)
CA (1) CA2319686C (xx)
DE (1) DE69909970T2 (xx)
DK (1) DK1052989T3 (xx)
EA (1) EA002676B1 (xx)
ES (1) ES2199541T3 (xx)
FR (1) FR2774592B1 (xx)
IL (2) IL137608A0 (xx)
NO (1) NO327819B1 (xx)
NZ (1) NZ506124A (xx)
PT (1) PT1052989E (xx)
WO (1) WO1999039710A1 (xx)
ZA (1) ZA99740B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872739B1 (en) * 1999-06-04 2005-03-29 Vereniging Voor Christelijk Wetenshappelikjk Onderwijs Use of riluzole for the treatment of multiple sclerosis
EP3801626A4 (en) * 2018-05-27 2022-02-23 Biohaven Pharmaceutical Holding Company Ltd. USE OF RILUZOL ORAL DISINFECTANT TABLETS TO TREAT DISEASES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2043070T3 (es) * 1988-12-15 1993-12-16 Rhone Poulenc Sante Procedimiento para la preparacion de derivados de la benzotiazolamina-2.
FR2700117B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2714828B1 (fr) * 1994-01-12 1996-02-02 Rhone Poulenc Rorer Sa Application du riluzole dans le traitement des maladies mitochondriales.
FR2726271B1 (fr) * 1994-10-26 1996-12-06 Rhone Poulenc Rorer Sa Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole

Also Published As

Publication number Publication date
EP1052989B1 (fr) 2003-07-30
FR2774592B1 (fr) 2000-03-17
JP5127092B2 (ja) 2013-01-23
AU2171199A (en) 1999-08-23
DK1052989T3 (da) 2003-11-17
KR20010040671A (ko) 2001-05-15
US6245791B1 (en) 2001-06-12
FR2774592A1 (fr) 1999-08-13
ATE245982T1 (de) 2003-08-15
NO327819B1 (no) 2009-09-28
JP2002502819A (ja) 2002-01-29
ES2199541T3 (es) 2004-02-16
NO20003785D0 (no) 2000-07-24
CA2319686C (fr) 2009-06-23
PT1052989E (pt) 2003-12-31
IL137608A (en) 2006-09-05
DE69909970T2 (de) 2004-05-27
AU761978B2 (en) 2003-06-12
WO1999039710A1 (fr) 1999-08-12
EA002676B1 (ru) 2002-08-29
NO20003785L (no) 2000-07-24
NZ506124A (en) 2003-07-25
EA200000816A1 (ru) 2001-02-26
KR100574378B1 (ko) 2006-04-26
CA2319686A1 (fr) 1999-08-12
EP1052989A1 (fr) 2000-11-22
DE69909970D1 (de) 2003-09-04
IL137608A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
ZA991578B (en) Compounds for the treatment of ischemia.
ZA200006042B (en) Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections.
PT1071422E (pt) Associações de riluzole e levodopa para o tratamento da doença de parkinson
CA2154572A1 (fr) Application du riluzole dans le traitement du neuro-sida
GC0000155A (en) 6-Hydroxy-indazole derivatives for treating glaucoma.
BG105197A (en) Polymorph form of a medicament
ZA995444B (en) A method for the treatment of staphylococcal disease.
WO1998027930A3 (en) New use of aminopiperazine derivatives
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
AU2002222180A1 (en) The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired pasticity
WO2001041709A3 (en) Methods for treating cell death diseases and inflammation
ZA99740B (en) Application of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction.
GR3032142T3 (en) Glucopyranoside benzothiophenes.
MXPA03004017A (es) Metodo para el tratamiento de inflamacion.
HK1038515A1 (en) Controlled delivery of antidepressants
PL352119A1 (en) Derivatives of aminotetraline for treatment of cardiovascular diseases
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
IL127930A0 (en) Verapamil as a medicament for the treatment of angina
GB9917158D0 (en) New use
ZA200006374B (en) Compound for the treatment of female sexual dysfunction.
AU4385499A (en) Pharmaceutical composition for treating sexual dysfunction
AU1209501A (en) Method for treating parkinson's disease by administering (-)-5-keto-2-n,n-di-n-propylamino-tetrahydrotetralin
WO2000007582A3 (en) Use of thiazolidinedione derivatives for the treatment or prevention of cataracts
AU2002218338A1 (en) Treatment of psychiatric disorders with trimethyl-bicyclo(2.2.1)heptane derivatives